ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2529

Molecular Mechanism of IgG4 Class Switch Recombination in IgG4-Related Disease

Hiroto Tsuboi1, Mana Iizuka1, Hiromitsu Asashima1, Sayaka Tsuzuki1, Yuya Kondo1, Akihiko Tanaka2, Masafumi Moriyama2, Isao Matsumoto1, Seiji Nakamura2 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Faculty of Dental Science, Kyushu University, Fukuoka, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: B cells, cytokines and immunoglobulin (IG), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

IgG4-related disease (IgG4-RD) is a new disease entity characterized by high serum IgG4 levels, IgG4-positive plasmacytic infiltration and fibrosis in various organs. Although the clinical features including serum abnormalities, organ involvement, diagnosis, and the therapeutic approach have been reported recently, the molecular mechanism of this disease remains unclear. The purpose of this study was to determine the mechanism of up-regulation of IgG4 class switch recombination in IgG4-RD.

Methods:

1)    We extracted RNA from PBMC of patients with IgG4-RD (n=6), Sjögren’s syndrome (SS) (n=6), and healthy control (HC) (n=8), from CD3 positive T cells and CD20 positive B cell sorted from PBMC of patients with IgG4-RD (n=3), SS (n=4), and HC (n=4). The RNAs were also prepared from labial salivary glands (LSG) of patients with IgG4-RD (n=11), SS (n=13), and HC (n=3).

2)    The mRNA expression levels of IgG4-specific class switch-related molecules such as Th2 cytokines (IL-4 and IL-13), Treg cytokines (IL-10 and TGFβ), transcriptional factors (GATA3 and Foxp3) were examined by quantitative PCR assay.

3)    IgG4-non-specific class switch related molecules such as CD40, CD154, BAFF, APRIL, IRF4, and AID were also examined by quantitative PCR assay.

Results:

1)    IgG4-specific class switch-related molecules. The mRNA expression level of IL-4 was significantly higher in LSG of IgG4-RD than HC (P<0.05). Treg cytokines (IL-10 and TGFβ) were significantly higher in LSG of IgG4-RD than SS and HC (P<0.05, each). There were no significant differences in the PBMC expression levels of various cytokines, among the three groups. In LSG, the expression of GATA3 was significantly lower in IgG4-RD than in SS, Foxp3 was significantly higher in IgG4-RD and SS than in HC (P<0.05, each).

2)    IgG4-non-specific class switch-related molecules. The mRNA expression levels of CD40 and CD154 were significantly lower in PBMC of IgG4-RD than SS (P<0.05, each). However, the expression of CD40 in CD20 positive B cells and that of CD154 in CD3 positive T cells were comparable in the three groups. The expression of BAFF was significantly higher in LSG of IgG4-RD than HC (P<0.05). The expression of APRIL was significantly lower in PBMC of IgG4-RD than HC (P<0.05). The expression of AID was significantly higher in LSG of IgG4-RD than SS and HC (P<0.05, each).

Conclusion:

In LSG of IgG4-RD, increased Treg cytokines (IL-10 and TGFβ) might play important roles in IgG4-specific class switch recombination and fibrosis, which are characteristic features of IgG4-RD. High expression of AID could also contribute to up-regulation of IgG4-specific class switch recombination along with IL-10 in LSG of IgG4-RD. Thus overexpression of IL-10, TGFβ, and AID in LSG might play important pathogenic roles in IgG4-RD. This study showed different expression levels of IgG4 class switch-related molecules in LSG than in PBMC of IgG4-RD, which suggested that IgG4 class switch recombination seem be mainly up-regulated in affected organs.


Disclosure:

H. Tsuboi,
None;

M. Iizuka,
None;

H. Asashima,
None;

S. Tsuzuki,
None;

Y. Kondo,
None;

A. Tanaka,
None;

M. Moriyama,
None;

I. Matsumoto,
None;

S. Nakamura,
None;

T. Sumida,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-mechanism-of-igg4-class-switch-recombination-in-igg4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology